Your account is not claimed yet. You can sign up with ORCID to claim your account.

Robert J DiDomenico

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Pharmacotherapy

Cardiovascular drugs and therapy

Circulation. Heart failure

Journal of the American College of Clinical Pharmacy : JACCP

University of Illinois at Chicago College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois at Chicago College of Pharmacy

United States

Associate Professor :: Pharmacy Practice

Publications

Robert J DiDomenico, Orly Vardeny
Optimizing Heart Failure Therapy Requires All-Hands-on-Deck and a DASH of Technology. Circulation. Heart failure (2023)
Brianna M McQuade, Eden Keller, Abigail Elmes, Robert J DiDomenico, Jennie B Jarrett
Stratification of burnout in health-system pharmacists during the COVID-19 pandemic: A focus on the ambulatory care pharmacist. Journal of the American College of Clinical Pharmacy : JACCP 5 (9) (2022)
William L Baker, Sobieraj D M, Robert J DiDomenico
Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews. Pharmacotherapy 41 (4) (2021)
Craig J Beavers, Robert J DiDomenico, Steven P Dunn, Jenna Cox, Long To, Phillip Weeks, Toby C Trujillo, Douglas L Jennings
Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy 41 (11) (2021)
Erika L Hellenbart, Tina Griffin, Robert J DiDomenico
Beyond Heart Failure and Ischemic Heart Disease: A Scoping Review of Novel Uses of Ivabradine in Adults. Pharmacotherapy 40 (6) (2020)
Kibum Kim, Daniel R Touchette, Larisa H Cavallari, Amer K Ardati, Robert J DiDomenico
Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome. Cardiovascular drugs and therapy 33 (5) (2020)
Haridarshan Patel, Gregory Sampang Calip, Robert J DiDomenico, Glen T Schumock, Katie J Suda, Todd A Lee
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms. Pharmacotherapy 40 (2) (2020)

Robert J DiDomenico.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert J DiDomenico